Chongqing Pharscin Pharmaceutical Co., Ltd. (SHE:002907)
China flag China · Delayed Price · Currency is CNY
14.00
+0.07 (0.50%)
Apr 30, 2026, 1:35 PM CST

SHE:002907 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
815.21764.14680.84774.72837.23
Other Revenue
11.9310.6810.710.478.91
827.14774.82691.54785.18846.14
Revenue Growth (YoY)
6.75%12.04%-11.93%-7.20%-4.12%
Cost of Revenue
353.96332.91312.45320.55400.53
Gross Profit
473.18441.91379.1464.63445.61
Selling, General & Admin
317.2308.36263.88292.53297.82
Research & Development
89.7659.1378.1258.8241.72
Other Operating Expenses
13.2212.1111.0112.3411.58
Operating Expenses
420.38381.01351.31367.04350.65
Operating Income
52.860.927.7897.5994.95
Interest Expense
-0.14--0.95-14.42-18.22
Interest & Investment Income
14.7910.329.8111.516.4
Currency Exchange Gain (Loss)
0.020-0--
Other Non Operating Income (Expenses)
-0.30.27-0.17-0.03-0.03
EBT Excluding Unusual Items
67.1771.4936.4894.6493.11
Gain (Loss) on Sale of Investments
1.421.38-4.67-2.61-1.33
Gain (Loss) on Sale of Assets
10.25-0.06--0.01
Asset Writedown
-0.44-0.03-2.37-0.17-
Other Unusual Items
-0.9420.613.316.3711.65
Pretax Income
77.4693.4442.8108.24103.42
Income Tax Expense
22.2516.7110.19.8411.64
Earnings From Continuing Operations
55.2176.7332.798.491.78
Minority Interest in Earnings
9.88----
Net Income
65.0976.7332.798.491.78
Net Income to Common
65.0976.7332.798.491.78
Net Income Growth
-15.17%134.66%-66.77%7.21%-22.99%
Shares Outstanding (Basic)
417418418403401
Shares Outstanding (Diluted)
417418418403401
Shares Change (YoY)
-0.05%0.02%3.60%0.49%0.06%
EPS (Basic)
0.160.180.080.240.23
EPS (Diluted)
0.160.180.080.240.23
EPS Growth
-15.13%134.61%-67.92%6.69%-23.04%
Free Cash Flow
47.68145.62126.52-47.5726.21
Free Cash Flow Per Share
0.110.350.30-0.120.07
Dividend Per Share
0.0750.0850.0500.0700.050
Dividend Growth
-11.77%70.00%-28.57%40.00%78.57%
Gross Margin
57.21%57.03%54.82%59.17%52.66%
Operating Margin
6.38%7.86%4.02%12.43%11.22%
Profit Margin
7.87%9.90%4.73%12.53%10.85%
Free Cash Flow Margin
5.76%18.79%18.30%-6.06%3.10%
EBITDA
138.5147.74109.68172.13164.7
EBITDA Margin
16.74%19.07%15.86%21.92%19.46%
D&A For EBITDA
85.786.8481.974.5469.74
EBIT
52.860.927.7897.5994.95
EBIT Margin
6.38%7.86%4.02%12.43%11.22%
Effective Tax Rate
28.72%17.89%23.59%9.09%11.25%
Revenue as Reported
827.14774.82691.54785.18846.14
Source: S&P Global Market Intelligence. Standard template. Financial Sources.